In light of these facts, NCL urges consumers to follow the advice of the AMA and global health bodies, all of which urge consumers not to self-inject research-grade synthetic peptides due to the serious safety risks associated with these peptides, including severe immune reactions and possible organ damage
Cao, Y., Yi, W., & Zhu, Q
Patients who discontinued tirzepatide due to planned pregnancy should inform their obstetric provider, as the medication should be stopped at least 1 month before a planned conception according to FDA labeling
Consuming a Protein and Fiber-Based Supplement Preload Promotes Weight Loss and Alters Metabolic Markers in Overweight Adults in a 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial